🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07549425
Active, not recruiting Observational

Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children

NCT07549425 · tracked via the Priya Life Science China tracker
Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Phase
Observational
Started
2026-01-01
Last updated
2026-04-24

Condition(s) studied

Neuroblastic Tumors

Study summary

The goal of this observational study is to build an intelligent ultrasound diagnostic system that integrates pathological typing, risk stratification and prognosis assessment. The main question it aims to answer is:

1. Can the prediction model of neuroblastoma tumors (NTs) in children based on ultrasound images distinguish each pathological subtype?
2. Can the multimodal fusion model established based on clinical and pathological features identify high-risk patients, predict bone marrow metastasis, and estimate the therapeutic effect?
3. Can this ultrasound diagnostic system achieve a systematic and intelligent assessment of NTs patients to assist in clinical risk stratification and individualized treatment decisions?

Eligibility

Sex
ALL
Min age
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: 1. The diagnosis of NTs was confirmed by surgical resection or biopsy with histopathological examination, and the type was classified as NB, GNB or GN according to the INPC standard. 2. Age ≤ 18 years old, with no gender restrictions. 3. There are complete abdominal (or primary site) ultrasound images archived, in original DICOM or JPG format, with image quality meeting the analysis requirements. 4. Complete clinical and pathological data relevant to the research purpose are available. Exclusion Criteria: 1. The patient has previously undergone surgical resection treatment in another hospital, but the tumor recurred or remained after the operation. 2. Poor quality of ultrasound images: There are artifacts that seriously affect the identification of tumor contours or feature extraction, image blurring, or incomplete display of the lesion. 3. Severe data deficiency: Key clinical pathological data or imaging data are missing, making it impossible to extract and analyze the required information.

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Anhui Provincial Children's Hospital Hefei Anhui
The Children's Hospital Affiliated to Soochow University Suzhou Jiangsu
Kunming Children's Hospital Kunming Yunnan
The Children's Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang
Zhejiang Cancer Hospital Hangzhou Zhejiang
Wenling Institute of Medical Big Data and Artificial Intelligence Wenling Zhejiang

More The Children's Hospital of Zhejiang University School of Medicine trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07549425 on ClinicalTrials.gov ↗ ← All trials in China